NCT03661788View on ClinicalTrials.gov

Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 6, 2017

Study Completion Date

June 27, 2018

Conditions
ADHD
Interventions
DRUG

Atomoxetine

14-day treatment interval: first week 40 mg atomoxetine (one pill), second week 80mg atomoxetine (two pills)

DRUG

Placebos

14-day treatment interval: first week one placebo pill, second week two placebo pills

Trial Locations (1)

52074

University Hospital RWTH Aachen, Aachen

All Listed Sponsors
lead

RWTH Aachen University

OTHER

NCT03661788 - Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD | Biotech Hunter | Biotech Hunter